Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study

Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study

The topic of the therapeutic use of cannabinoids in Parkinson’s disease (PD) is broadly discussed and frequently comes up in the outpatient clinic. So far, there are only a few randomized clinical trials assessing the effects of cannabinoids in PD. We are able to demonstrate a reduction in non-motor...

Full description

Bibliographic Details
Main Authors: Philipp Ellmerer, Marina Peball, Federico Carbone, Marcel Ritter, Beatrice Heim, Kathrin Marini, Dora Valent, Florian Krismer, Werner Poewe, Atbin Djamshidian, Klaus Seppi
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Brain Sciences
Subjects:
Parkinson’s disease
nabilone
cannabis
eye-tracking
non-motor symptoms
Online Access:https://www.mdpi.com/2076-3425/12/5/661

Internet

https://www.mdpi.com/2076-3425/12/5/661

Similar Items